POSNOC-POsitive Sentinel NOde: adjuvant therapy alone versus adjuvant therapy plus Clearance or axillary radiotherapy: a randomised controlled trial of axillary treatment in women with early-stage breast cancer who have metastases in one or two sentinel nodes.

Goyal A, Mann GB, Fallowfield L, Duley L, Reed M, Dodwell D, Coleman RE, Fakis A, Newcombe R, Jenkins V, Whitham D, Childs M, Whynes D, Keeley V, Ellis I, Fairbrother P, Sadiq S, Monson K, Montgomery A, Tan W, Vale L, Homer T, Badger H, Haines RH, Lewis M, Megias D, Nabi Z, Singh P, Caraman A, Miles E, POSNOC Trialists

Open source

DOI
10.1136/bmjopen-2021-054365
Published
2021 Dec 2
Container
BMJ open
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/bmjopen-2021-054365,
  title = {POSNOC-POsitive Sentinel NOde: adjuvant therapy alone versus adjuvant therapy plus Clearance or axillary radiotherapy: a randomised controlled trial of axillary treatment in women with early-stage breast cancer who have metastases in one or two sentinel nodes.},
  author = {Goyal A and Mann GB and Fallowfield L and Duley L and Reed M and Dodwell D and Coleman RE and Fakis A and Newcombe R and Jenkins V and Whitham D and Childs M and Whynes D and Keeley V and Ellis I and Fairbrother P and Sadiq S and Monson K and Montgomery A and Tan W and Vale L and Homer T and Badger H and Haines RH and Lewis M and Megias D and Nabi Z and Singh P and Caraman A and Miles E and POSNOC Trialists},
  year = {2021},
  journal = {BMJ open},
  doi = {10.1136/bmjopen-2021-054365},
  url = {https://doi.org/10.1136/bmjopen-2021-054365}
}

RIS

TY  - JOUR
TI  - POSNOC-POsitive Sentinel NOde: adjuvant therapy alone versus adjuvant therapy plus Clearance or axillary radiotherapy: a randomised controlled trial of axillary treatment in women with early-stage breast cancer who have metastases in one or two sentinel nodes.
AU  - Goyal A
AU  - Mann GB
AU  - Fallowfield L
AU  - Duley L
AU  - Reed M
AU  - Dodwell D
AU  - Coleman RE
AU  - Fakis A
AU  - Newcombe R
AU  - Jenkins V
AU  - Whitham D
AU  - Childs M
AU  - Whynes D
AU  - Keeley V
AU  - Ellis I
AU  - Fairbrother P
AU  - Sadiq S
AU  - Monson K
AU  - Montgomery A
AU  - Tan W
AU  - Vale L
AU  - Homer T
AU  - Badger H
AU  - Haines RH
AU  - Lewis M
AU  - Megias D
AU  - Nabi Z
AU  - Singh P
AU  - Caraman A
AU  - Miles E
AU  - POSNOC Trialists
PY  - 2021
JO  - BMJ open
DO  - 10.1136/bmjopen-2021-054365
UR  - https://doi.org/10.1136/bmjopen-2021-054365
ER  - 

APA

A, G., GB, M., L, F., L, D., M, R., D, D., RE, C., A, F., R, N., V, J., D, W., M, C., D, W., V, K., I, E., P, F., S, S., K, M., A, M., W, T., L, V., T, H., H, B., RH, H., M, L., D, M., Z, N., P, S., A, C., E, M., & Trialists, P. (2021). POSNOC-POsitive Sentinel NOde: adjuvant therapy alone versus adjuvant therapy plus Clearance or axillary radiotherapy: a randomised controlled trial of axillary treatment in women with early-stage breast cancer who have metastases in one or two sentinel nodes.. BMJ open. https://doi.org/10.1136/bmjopen-2021-054365

Source records